
Bacteromic sp. z o.o.
Other research and experimental development on natural sciences and engineering
Overview
Bacteromic is a diagnostic system that focuses on determining antibiotic susceptibility using microfluidic technology. It addresses the global issue of antibiotic resistance by providing phenotypic assessments of antibiotic effectiveness. The system aims to combat multidrug resistance, which poses significant challenges in modern medicine.
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 57 days early. All were audited by a statutory auditor.
- 202527/04/2026
- 202403/07/2025
- 202307/06/2024
- 202203/04/2023
- 202104/07/2022
- 202007/07/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Diagnostic system for antimicrobial susceptibility testing
- Antimicrobial susceptibility testing
- Detection of bacterial resistance mechanisms
Websites
The site is available in: Polish and English.
- bacteromic.comStrona główna – BACTEROMICWordPress 3.7ElementorGoogle Tag ManagerRRank MathWWPMLCloudflareLLiteSpeed
Trademarks
The company holds 2 active trademarks registered with the Polish Patent Office. The first mark was filed in 2021.
| Mark | Number | Classes | Status | Protected until | |
|---|---|---|---|---|---|
| Bacteromic (word) | Z.572229 | 1, 5, 9, 10 | Protected | Jul 19, 2034 | |
| BACTEROMIC | Z.523984 | 1, 5, 9, 10 | Protected | Feb 2, 2031 |
| Mark | Protected until | |
|---|---|---|
| Bacteromic (word) | Jul 19, 2034 | |
| BACTEROMIC | Feb 2, 2031 |
Job offers
The company has its own careers page: bacteromic.com/kariera.
Authorized Representatives
Manner of representation
In the case of a one-person management board, the company shall be represented by the sole member of the management board acting independently. In the case of a multi-member management board, the company shall be represented by two members of the management board acting jointly, or one member of the management board jointly with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 762,100 | $10,293,084.82 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2017-03-30.
52 2490 1057 0000 9900 4492 4537
02 2490 0005 0000 4520 3307 9505
27 2490 0005 0000 4600 2743 0667
Debt
No entries in the National Debtors Register (KRZ).
Public aid
7 public aid cases recorded, with a total value of $680,510.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Mar 17, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Marszałek Województwa Mazowieckiego | |
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych |
European Funds
4 projects recorded: 3 from FE lists ($1,130,513) and 1 Commission grant (FTS) ($2,156,328).
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2019-08-01 | Intelligence for precision therapies against antimicrobial resistance: the first diagnostic panel that probes all the clinically relevant antibiotics at once | $2.2M$2,156,328 | 1.1.31 - Horizon 2020 | |
| 2018-06-01 | Obtaining international patent protection for the invention "Metoda szybkiego wykrywania wzrostu bakterii" | $53,523$53,523 | Operational Programme Smart Growth | |
| 2018-05-01 | Obtaining international patent protection for the inventions "Chip mikroprzepływowy" and "Segment inkubacyjny" | $98,564$98,564 | Operational Programme Smart Growth |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Seamaty Polska sp. z o.o. | $946,343.12 | seamaty.pl | ||
| Tecom Analytical Systems-Poland sp. z o.o. | $761,763.14 | tecom.com.pl | ||
| Oasis Diagnostics S.A. | $282,613.94 | oasis-diagnostics.com | ||
| Brain Optics sp. z o.o. | $103,370.62 | brainoptics.eu | ||
| GMT Id S.A. | $37,578.35 | genomtec.com | ||
| V-Lab sp. z o.o. | $16,594.61 | vlab.com.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-10-07 | Share capital increase (37,105,000.00 PLN → 38,105,000.00 PLN) | |
| 2026-05-15 | Share capital increase (35,105,000.00 PLN → 37,105,000.00 PLN) | |
| 2025-10-28 | Share capital increase (34,105,000.00 PLN → 35,105,000.00 PLN) | |
| 2025-06-02 | Share capital increase (33,105,000.00 PLN → 34,105,000.00 PLN) | |
| 2024-11-25 | Share capital increase (32,105,000.00 PLN → 33,105,000.00 PLN) |
FAQ
Last updated: 2026-11-12